Poly Cystic Ovarian Syndrome (PCOS) Study

Enroll Now

  • This field is for validation purposes and should be left unchanged.

Type of Study:

Polycystic Ovary Syndrome (PCOS)

Title of Study:

Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome

Short Title:

This study will assess the potential impact of Elagolix on disordered pituitary and ovarian hormones in women with Polycystic Ovary Syndrome (PCOS).

Study Length: 8 to 9 months

Target Age/Sex: 18 Years to 35 Years, Female


Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.